Congenital creatine transporter deficiency
T J deGrauw1, G S Salomons, K M Cecil
1Division of Neurology, Cincinnati Children's Hospital Medical Center and College of Medicine, University of Cincinnati, Ohio 45229-3039, USA. Ton.degrauw@cchmc.org
Background:
Two inborn errors of metabolism of creatine synthesis as well as the X-linked creatine transporter (SLC6A8) deficiency have been recognized. This report describes the features of five identified male patients and their female relatives who are carriers of the X-linked creatine transporter deficiency syndrome.
Methods:
Proton MR spectroscopy was used to recognize creatine deficiency in the patients. Molecular analysis of the SLC6A8 gene was performed, confirming the diagnosis of homozygous males and heterozygous females.
Results:
We describe four families from a metropolitan area in the U. S. with X-linked creatine transporter deficiency. All affected males present with developmental delay and severe developmental language impairment. Proton MR spectroscopy shows significantly depressed to essentially absent creatine and phosphocreatine in the male patients. Nonsense mutations and amino acid deletions were found in the SLC6A8 gene in the affected families.
Conclusion:
Creatine transporter deficiency may be a more common X-linked genetic disorder than originally presumed. The affected males exhibit mental retardation with severe expressive language impairment.
More Related Videos
Related Concept Videos
ATP Synthase: Mechanism
The ADP/ATP Carrier Protein
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters


